Trials / Recruiting
RecruitingNCT06202027
Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Kyowa Kirin Korea Co., Ltd. · Industry
- Sex
- All
- Age
- 1 Day
- Healthy volunteers
- —
Summary
The objective of this post-marketing surveillance (PMS) study is to assess the safety and effectiveness of CRYSVITA injection 10, 20, and 30mg, equivalent to in routine clinical settings
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FGF23-related hypophosphataemic rickets and osteomalacia | FGF23-related hypophosphataemic rickets and osteomalacia |
Timeline
- Start date
- 2023-08-11
- Primary completion
- 2031-06-16
- Completion
- 2031-07-16
- First posted
- 2024-01-11
- Last updated
- 2025-08-29
Locations
13 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06202027. Inclusion in this directory is not an endorsement.